PNNL biomedical scientist Josh Adkins brings expertise analyzing biomolecules in dynamic systems.

PNNL-developed Water Balance Tool estimates consumption for major water end-uses. Understanding the breakout of water use identifies water efficiency opportunities and allows facility managers to spot potential system losses.

Genetic and integrated multi-omic details of glioblastoma could one day inform new therapies.

The Metabolomics Association of North America promotes the field’s development across the continent.

Buildings account for around 40 percent of our nation's energy use and consume 75 percent of our nation’s electricity each year. Energy use is also one of the biggest costs for facility owners.

Researchers propose and test foundational concepts for the new subdiscipline of “meta-metabolome ecology.”

PNNL’s longstanding grid and buildings capabilities are driving two projects that test transactive energy concepts on a grand scale and lay the groundwork for a more efficient U.S. energy system.

PNNL researchers are looking for protein signatures that could provide information about how the body's immune system responds to COVID-19.

PNNL cancer cell biologist Karin Rodland has been recognized by the international Human Proteome Organization.

Twelve researchers from PNNL presented at the 2020 Metabolomics Association of North America virtual conference in mid-September. Their presentations included a plenary talk, keynote talks, oral presentations, posters, and a lightning talk.

Pacific Northwest National Laboratory (PNNL) is part of a continuing National Science Foundation (NSF) team investigating the environmental impact of nanoparticles at the molecular level.

Researchers from PNNL have helped colleagues at OHSU identify lipid molecules required for Zika infection in human cells. The specific lipids involved could also be a clue to why the virus primarily infects brain tissue.

Researchers from 25 institutions around the country, including PNNL, are working to find out how exercise changes the molecular makeup of our cells to generate health benefits.

After 50 years in science and on the eve of retirement, Laboratory Fellow Karin Rodland, a cancer cell biologist at PNNL, is working on experiments she has dreamed about for decades.

Accurate identification of metabolites, and other small chemicals, in biological and environmental samples has historically fallen short when using traditional methods.

A new study using proteogenomics to compare cancerous tissue with normal fallopian tube samples advances insights about the molecular machinery that underlies ovarian cancer.

Artificial intelligence helps researchers identify metabolites, the small molecules that underlie life.

PNNL scientists are on the front lines fighting against biological threats through early detection, diagnosis, and prevention strategies.

A new study focusing on the proteins involved in endometrial cancer, commonly known as uterine cancer, offers insights about which patients will need aggressive treatment and which won’t.

PNNL’s Intelligent Load Control technology manages and adjusts electricity use in buildings when there’s peak demand on the power grid.